loader

articles

13 results (tag: Drugs)

Investments in research and development, a way out of the crisis generated by COVID-19. How is Romania positioned?

Opinion material by Corina Simion, Direct Tax Manager, and Alexandra Preda, Direct Tax…

Leveraging Technology is Helping Non-Grocery Retailers to Cope with Coronavirus

Governments around the world increasingly require non-essential stores to close as part…

41 new latest generation drugs received approval in 2014

In 2014, the Drug Research and Evaluation Center within the Food and Drug Administration…

Romania vs. Central and South Eastern Europe (CSE) – a comparative view on the pharmaceutical sectors

The local pharmaceutical sector continues its upward trajectory in 2013 in terms of sales,…

ERNST & YOUNG…
Despite the boom on the capital markets, the global biotechnology industry needs a new paradigm of research and development

The global biotechnical industry had a powerful comeback in 2013, with the companies listed…

ERNST & YOUNG…
Better ammunition for intellectual property rights holders against counterfeiting and piracy – the new european customs enforcement regulation

Whether it is related to innovation, advancement of modern technologies, brand identity,…

Cash flows more difficult for big pharma

Big pharma firms have between US$20b and US$40b of cash unnecessarily tied up in…

ERNST & YOUNG…
Mobile technology poised to enable a new era in health care

Smart mobile technology is poised to transform global health care — with a little…

ERNST & YOUNG…
Pharmaceutical Market – Reaping the fruits of past actions

After, 2009 and 2010, years with double-digit growth, the chronic underfunding and the…

Romanian pharmaceutical market, report by Roland Berger Strategy Consultants

The local pharmaceutical market is one of the few economic sectors least affected by…

Acute or chronic: the impact of economic crisis on healthcare, report by KPMG Romania

The deepening economic crisis in the Eurozone has exposed health systems around the world,…